Delayed severe abciximab-induced thrombocytopenia: A case report
Conclusion Although specific mechanisms of abciximab-related thrombocytopenia are still unclear and the management is not well established, the patient responded well to the therapy and his recovery was uneventful.
Source: Heart and Lung: The Journal of Acute and Critical Care - Category: Respiratory Medicine Source Type: research
More News: Abciximab | Angiography | Cardiology | Clopidogrel | Dexamethasone | Heart | Plavix | Respiratory Medicine | Thrombocytopenia | Thrombosis